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MRI gradingAbstract Background: It is crucial to accurately differentiate HGGs from LGGs, as treatment
strategies vary. Our study aims to assess the sensitivity and speciﬁcity of fractional anisotropy
(FA) values derived from diffusion tensor imaging (DTI) and dynamic contrast enhanced
perfusion-weighted imaging (PWI) in differentiating HGGs from LGGs.
Materials: 15 patients with HGGs and 9 LGGs were examined. Mean, Minimal and Maximal FA
fractional anisotropy in tumour, necrotic area and in surrounding oedema, as well as (rCBV) ratio
of the lesions were measured and compared between LGG and HGG. The efﬁcacy of the above
parameters in grading gliomas was evaluated. In perfusion MRI, we measure rCBV ratio as param-
eter of neovascularity of tumour.
Results: The use of MR DTI had an important role in the grading of brain gliomas as it was accu-
rate in grading 24 cases. There was signiﬁcant correlation between histopathological grade and FA
values measured in tumour and necrotic areas. No positive correlation in perifocal areas could be
established. Our results show signiﬁcant difference between HGG and LGG with mean rCBV ratio
as 2.62 & 0.79 with best cut-off value (1.2).
Combined use of MR DTI and MR perfusion added to the accuracy of grading of glioma.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).1. Introduction
Imaging plays a crucial role in the management of patients
with brain tumours, and the development of new MRI imagingtechniques strongly improved the detection and characteriza-
tion of brain tumours (1).
Advances in imaging, are being used by neurosurgeons to
target aggressive areas in gliomas, and to help identify tumour
boundaries, functional areas and tracts. Neuro-oncological
surgeons need to understand these techniques to help maxi-
mize tumour resection, while minimizing morbidity in an
attempt to improve the quality of patient outcome. Multi-
modality MRI is being used for pre-operative imaging assess-
ments and allows informed decisions on operative planning
244 E.A.SH. Geneidi et al.and surgical resection. Each technique has speciﬁc advantages
over standard imaging (2).
Gliomas are the most common primary tumours of the cen-
tral nervous system and represent about one third of all
intracranial tumours in adults. MRI has been the lifelong
established method for evaluating such tumours both before
and after treatment. However the use of conventional MRI
limits the application of MRI to the morphological informa-
tion. The newly developed concept of obtaining both morpho-
logical and physiological information in a single examination
is highly attractive. Roberts et al. study described physiologic
imaging as incorporation of many tools. It includes evaluating
blood volume, diffusional motions, vascular permeability as
well as the cellular metabolic proﬁles (3).
Hartmann et al. study pointed that despite optimization of
sequences and protocols, the classiﬁcation and grading of glio-
mas with conventional MR imaging is sometimes unreliable,
with the sensitivity for glioma grading ranging from 55.1%
to 83.3% (4).
A point of prime importance is that contrast agents in use,
are actually non-speciﬁc to tumour tissue and their grade, but
rather, they enhance in area where the blood-brain barrier has
become permeable. Thus we needed to apply a technique that
actually assesses tumour neovascularity rather than contrast
leakage. This was possible by applying perfusion MR tech-
nique (5).
Moreover, the prognosis for patients with gliomas relies on
the histopathology grading, whereas the prognosis for those
with high-grade gliomas (HGGs) remains very poor compared
to the low-grade gliomas (LGGs) (6). In patients with HGGs,
surgical resection followed by adjuvant chemo-radiotherapy
represents the standard of care (7). As for those with LGGs,
the optimal therapeutic measure includes offering extensive
resection of the tumour, if possible, and delaying adjuvant
radiotherapy postoperatively until the time of glioma progres-
sion (8). So, it is crucial to accurately differentiate HGGs from
LGGs preoperatively, as well as follow-up on LGG tumours
with early detection of any residual/recurrent tumoural regions
(see Figs. 1 and 2).
Dynamic susceptibility-weighted contrast-enhanced
perfusion-weighted imaging (DSC-PWI) is a well-established
technique in grading cerebral gliomas and predicting prognosis
(9–13). Law et al. proposed a relative cerebral blood volume
(rCBV) ratio cut-off value of 1.75 to distinguish LGG from
HGG (11).
As an advanced magnetic resonance images (MRI) tech-
nique, diffusion tensor imaging (DTI) provides visibility into
the motion of water molecules. Fractional anisotropy (FA) is
the commonly used key metric of DTI, which represents a
metric of the directionality of molecular movement (14).
The value of FA in preoperative grading of gliomas is still
controversial.
The purpose of this study is to evaluate various imaging
parameters, including maximal rCBV, Mean, Min and Maxi-
mal FA that may aid in differentiation of LGG from HGG.
2. Materials and methods
MR examinations of 24 patients (mean age 29 ± 13) were
done, 18 male, 6 females with brain tumours. Biopsy of all
patients was done and there were 9 patients with LGG and15 patients with HGG. A standard 1.5 Tesla unit (Gyroscan
T10 NT, Philips) with a standard head coil was used. All
patients were subjected to the following MRI protocols;
Sequence Parameters taken
Pre- and postcontrast axial,
coronal and sagittal T1
weighted spin echo (T1WI)
(T1 SE) TR of 652 ms, a TE of
13 ms, a 256  256 acquisition
matrix, a ﬁeld of view of
240 mm, a slice thickness of
5 mm and a gap of 1 mm
Axial T2 weighted turbo spin
echo (T2 WI)
(TR) of 4000 ms, (TE) of
106 m, a slice thickness of
5 mm, a gap of 1 mm,
256  256 acquisition matrix,
FOV= 240 mm
Axial FLAIR TR of 9000 ms, a TE of
107 ms, TI 2000 ms a ﬁeld of
view of 240 mm, a slice
thickness of 5 mm and a gap of
1 mm
Diﬀusion Tensor imaging
(DTI)
Consisted of a single shot,
spin-echo echo planar
sequence in 12 encoding
directions and a diﬀusion-
weighting factor (b value) of
1000 s/mm2. TR 2800, TE 94,
matrix 128  128, FOV
240  240 mm, number of
excitations 2, slice thickness:
2.0/00 and ﬂip angle 90
(degrees)
Perfusion MR Carried out using a lipid-
suppressed echo planar
sequence utilizing the
following parameters: TR,
1520 s; TE, 32 ms, Slice
thickness, 5 mm. axial slice
orientation to cover the entire
tumour, maximum of 19 slices;
Matrix size, 128  128; ﬁeld of
view, 240 mm. A series of 40
acquisitions at 1 s interval was
acquired. Intravenous contrast
injection was done after ﬁve
baseline acquisitions were
acquired. With the pressure
injector a dose of 0.2-mmol/kg
bodyweight gadopentetate
dimeglumine (Gd-DTPA), was
injected at a rate of 5 mL/s
through an 18-G cannula
placed in the antecubital
region and immediately
followed by 20 ml injection of
salineAll the diffusion-weighted images were transferred to the work-
station and images were post-processed using the Philips soft-
ware devised for tractography. The maps obtained were as
follows: FA maps, directionally encoded color FA map, 3D
ﬁbre tractography maps. The direction and anatomy of the
Fig. 1 Diagnostic performance of rCBV ratio parameter in
discriminating between HGG & LGG.
Fig. 2 Bivariate rCBV ratio and (minimal, maximal and mean
FA tumour area).
Table 1 Descriptive data of the study patients with regard to
different parameters.
Parameters High grade Low grade
Mean ±SD Mean ±SD
Age (years) 42.33 10.57 16.33 7.71
rCBV ratio 2.62 0.75 0.79 0.20
Tumour FA
Minimal 137.13 45.33 73.11 23.35
Maximal 293.60 77.83 155.56 25.05
Mean 215.37 60.20 114.33 21.30
Perifocal area FA
Minimal 296.33 134.22 206.44 101.90
Maximal 473.73 186.05 392.00 238.88
Mean 385.03 155.06 299.22 143.56
Necrotic
Minimal 29.67 5.76 61.50 26.88
Maximal 80.83 44.09 125.83 41.18
Mean 55.25 22.80 93.67 25.40
Data are expressed as mean ± SD for each parametric.
Table 2 Histopathological grades distribution within study
group.
Histopathological Frequency Percentages (%)
High grade 15 62.5
Low grade 9 37.5
Total 24 100
Table 3 Comparison between histopathological and (rCBV
ratio) of tumour.
High Low t-test
Mean ±SD Mean ±SD T p-value
rCBV ratio 2.62 0.74 0.79 0.23 7.157 <0.01 (HS)
Table 4 Diagnostic performance of rCBV ratio in discrimi-
nation between HGG & LGG in PWI.
Cut-oﬀ value Sens. Spec. +PV PV AUC
rCBV ratio >1.2 100.0 100.0 100.0 100.0 100.0
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speciﬁc color is assigned to tracts running in the three orthog-
onal planes. A 3D display of tracts was created. For creating
3D ﬁbre tracts, a ROI (or seed) was drawn (placed) along
the course of the tract in the (axial, sagittal or coronal) color
encoded FA map in single or consecutive sections. The soft-
ware then automatically traces the assigned tract and presents
it in a 3D manner. Three regions of interest (ROIs) were drawn
at tumour solid portion, perifocal area and necrotic area of
tumour where FA values are measured. Color-coded DTI
maps were analyzed, followed by tractography of individual
tracts. In most of patients the tumour was isolated to one
hemisphere, The location of each tract and its hue on direc-
tional color maps were classiﬁed as normal or abnormal, basedon comparison to the homologous tracts in the contralateral
hemisphere, which were unaffected by tumour. We adopted
the criteria developed by Cruz et al at 2007 to classify ﬁbre
tract involvement into 4 categories: Deviated (Displaced),
Oedematous, Inﬁltrated and Destructed (Disrupted).
For perfusion MRI, series of 40 images was obtained and
analyzed, and the start- and end-points of the ﬁrst pass transit
were calculated from the means of the signal intensities of all
the pixels covering the brain. Because the change in the T2*
relaxation rate is linearly proportional to the concentration
Table 5 Comparison between histopathological and tumour
FA of the study group.
Tumour FA
(1/1000)
High Low t-test
Mean ±SD Mean ±SD T p-value
Minimal 137.13 45.33 73.11 23.35 4.631 <0.01
(HS)
Maximal 293.60 77.83 155.56 25.05 5.124 <0.01
(HS)
Mean 215.37 60.20 114.33 21.30 6.82 <0.01
(HS)
Table 6 Diagnostic performance of FA values as a parameter
in discrimination between HGG & LGG from tumour portion.
Tumour FA (1/
1000)
Cut-oﬀ
value
Sens. Spec. +PV PV AUC
Minimal >85 93.3 77.8 87.5 87.5 88.9
Maximal >190 100.0 100.0 100.0 100.0 100.0
Mean >135 100.0 100.0 100.0 100.0 100.0
Table 7 Comparison between histopathological and perifocal
FA of the study group.
Perifocal FA
(1/1000)
High Low t-test
Mean ±SD Mean ±SD T p-
246 E.A.SH. Geneidi et al.of contrast in the tissue, the same was calculated on a pixel-to
pixel basis using the formula ((S/So)/TE), where So is the base-
line signal intensity, S is the change in the signal intensity and
TE is the echo time. Thus a time–signal intensity curve was
essentially changed to a time–concentration curve.
Analysis was then performed on the time–concentration
curve and the various perfusion parameters were calculated.
The relative cerebral blood volume (rCBV) maps were gener-
ated from an integration of the DR2* values from the start
to the end of the ﬁrst pass of the contrast. The rCBV of the
tumour was normalized with respect to that of the contralat-
eral normal white matter taken as a reference. The CBV and
CBF maps were analyzed with respect to heterogeneity on
visual inspection and by placing region of interests in hot spots
of the tumours. The rCBV ratios were normalized with respect
to the contralateral white matter.
Data were analyzed using Statistical Program for Social
Science (SPSS) version 18.0. Quantitative data were expressed
as mean ± standard deviation (SD). Qualitative data were
expressed as frequency and percentage.
The following tests were done:
 Independent-samples t-test of signiﬁcance was used when
comparing between two means.
 Chi-square (X2) test of signiﬁcance was used in order to
compare proportions between two qualitative parameters.
 Pearson’s correlation coefﬁcient (r) test was used for corre-
lating data.
 Receiver operating characteristic (ROC curve) analysis was
used to ﬁnd out the overall predictivity of parameter in and
to ﬁnd out the best cut-off value with detection of sensitivity
and speciﬁcity at this cut-off value, positive predictive
value (PPV), negative predictive value (NPV) Probability
(P-value)
– P-value <0.05 was considered signiﬁcant.
– P-value 0.01 was considered as highly signiﬁcant.
– P-value >0.05 was considered insigniﬁcant.
The placement of ROIs in PWI and DTI data analysis was
decided by consensus of 2 of the authors who have 8 and
7 years of experience in MR PWI and DTI data analysis,
respectively, who were blinded to the histopathological and
clinical information.value
Minimal 296.33 134.22 206.44 101.90 1.727 0.098
Maximal 473.73 186.05 392.00 238.88 0.937 0.359
Mean 385.03 155.06 299.22 143.56 1.35 0.191
Table 8 Comparison between histopathological grades and
necrotic area FA values of the study group.
Necrotic area
FA (1/1000)
High Low t-test
Mean ±SD Mean ±SD T p-value
Minimal 29.67 5.76 61.50 26.88 4.039 <0.01
(HS)
Maximal 80.83 44.09 125.83 41.18 2.083 0.054
Mean 55.25 22.80 93.67 25.40 3.25 <0.01
(HS)3. Results
Twenty-four patients, compromising 18 males and 6 females,
ranging in age from 8 to 58 years with a mean age of 29 years
were included in the current study. All patients were evaluated
with pre- and postcontrast conventional MR studies as well as
DTI and contrast enhanced MR perfusion study (Table 1).
We studied 24 patients including 15 cases pathologically
proven to have high-grade gliomas, 3 cases didn’t enhance
on conventional images (20%) while 9 cases proved to have
low-grade gliomas, out of which 2 cases showed heterogeneous
enhancement (22%).
In perfusion MRI, we measure rCBV ratio as parameter for
assessment of neovascularity of tumour in hot spot technique
in comparison with the contralateral area, and the results weremean rCBV ratio for HGG & LGG as (2.62 & 0.79 respec-
tively) with cut-off value (1.2).
This table shows the signiﬁcant difference between
histopathological (high and low grades) in regards of rCBV
ratio, using independent sample t-test, with p-value <0.01
HS (see Tables 2–4).
Receiver operating characteristics (ROC) curve was used to
deﬁne the best cut-off value of the rCBV ratio which was
>1.2, with sensitivity of 100, speciﬁcity of 100, positive predic-
tive value of 100, negative predictive value of 100 with AUC
100.
In DTI MR examination, we do assessment of tumours by
measuring FA values (Min, Max & Mean) at 3 ROIs (at solid
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patient.
First ROI: Solid tumoral portion, FA values were as in fol-
lowing Table 5:
This table shows the signiﬁcant difference between
histopathological (high and low grades) in regard to tumour
portion FA values, and there was highly statistically signiﬁcant
difference, using independent sample t-test, with p-value
<0.01 HS.
At tumoural solid portion, ROC curve was used to deﬁne
the best cut-off value for the Minimal, Maximal and Mean
FA, with sensitivity, speciﬁcity, positive predictive, negative
predictive values and area under the curve (AUC) for each
were recorded and compared (see Table 6).
Second ROI: Perifocal area, FA values were as in following
Table 7:
This table shows no signiﬁcant difference among
histopathological grades (HGG & LGG) in regard to perifocal
FA values, using independent sample t-test, with p-value
>0.05 NS.
The third ROI: Necrotic area of tumour, FA values were as in
following Table 8:
This table shows the statistically signiﬁcant difference
between histopathological grades (HGG & LGG) in regard
to Min & Mean FA and non-signiﬁcant Max FA, using inde-
pendent sample t-test.
Combination of perfusion (rCBV ratio) & DTI (FA) MRI
examinations with conventional MRI can raise the sensitivity
and speciﬁcity of performance in grading of gliomas into
HGG & LGG upto 100% (see Figs. 3–7).
4. Discussion
The recent advances in brain tumour imaging offer unique
anatomical as well as pathophysiological information that pro-
vides new insights on brain tumours, directed on facilitating
the new therapeutic decisions and proving information regard-
ing the prognosis (15).
Conventional MR imaging readily provides evidence of
enhancement, signifying blood-brain barrier breakdown,Fig. 3 Male patient (8 years old) is complaining from headache
for 3 months ago & attacks of vomitting. (a) T2 & T1 (Pre- &
Post-contrast) weighted MR imaging show well deﬁned solid mass
involving the anterior aspect of midbrain measures 2.3  2  2 cm
in diameter, moderate hypointense T1, hyperintense T2, and
heterogenous contrast enhancement in T1 postcontrast. (b) Color
coded FA image & quantitative FA image show: Min/Max FA &
mean FA values for tumour (1) & perifocal area (2) as marked
above in corresponding image. (c) 3D tractography showing
smooth lateral displacement of the left corticospinal tracts (d)
Susceptibility signal intensity -time curve with regions of interest
over tumour (- - - - - - - -) and contralateral brain (. . .. . .. . .) shows
low rCBV ratio within the lesion. rCBV = 0.95. Final MRI
diagnosis after DTI and MR perfusion: low grade glioma displacing
tracts rather than inﬁltrating with low FA values which is further
conﬁrmed by low rCBV. Histopathological report: Low grade
(grade I & II WHO grading).
3
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contrast enhancement alone is not always accurate in predict-
ing tumour grade as encountered in our study.
A study by Law et al., carried out on 160 patients, reported
that sensitivity for differentiation between low and high-grade
gliomas with conventional MR imaging was 72.5%. (16–18) as
characterization depending on contrast enhancement, perifocal
oedema, haemorrhage, necrosis and mass effect, can be some-
times difﬁcult esp. in atypical cases. Ginsberg et al. study was
performed upon 50 patients, and reported that one fourth of
low-grade gliomas (25%) showed enhancement and one ﬁfth
of high-grade gliomas (20%) did not (19).
We studied 24 patients including 15 cases pathologically
proven to have high-grade gliomas, 3 cases didn’t enhance
on conventional images (20%) while 9 cases proved to have
low-grade gliomas, out of which 2 cases showed heterogeneous
enhancement (22%). All patients are examined using conven-
tional MRI pre- and postcontrast, DTI & PWI.
Regarding DTI, three spots (ROIs) were taken in FA map
at the following: tumour (solid portion), perifocal area &
necrotic area & were considered as parameters to our study.
The values of Min, Max and Mean FA in tumour area &
the value of Minimal & Mean FA in necrotic area were signif-
icantly different in HGG than that in LGG, with higher sensi-
tivity and speciﬁcity in the grading of gliomas than the other
imaging parameters. Our study could not detect any signiﬁcant
difference between the LGG and HGG with regard to Max,
Min & Mean FA in perifocal area & Max FA in necrotic area.
Our results are in consensus with the study by Lee et al. (20)
who stated that FA has been used to grade gliomas, and show
a trend towards higher FA values in HGG relative to LGG.
Min, Mean and Maximal FA values at tumour areas in our
study were also signiﬁcantly higher in HGG when compared
with LGG. These ﬁndings are consistent with the results inFig. 4 (a–c) T2 & T1 (Pre- & Post-contrast) weighted MR
imaging shows the following: well deﬁned soft tissue mass
involving the left thalamus and extending downward to involve
the central and dorsal aspects of the upper midbrain. It measures
around 4.5 * 4.5 * 2.5 cm. It appears as homogenous iso-intense in
T1, hyperintense in T2, with minimal perifocal oedema with
effacement of third ventricle & shows no signiﬁcant enhancement
in T1 postcontrast. (d) Color coded FA image & quantitative FA
image show the following: Min/Max FA & Mean FA values for
tumour area (1) & perifocal area (2). (e) 3D tractography showing
displacement of the left optic radiation inferomedially & ipsilateral
meyer”s loop is crossing along the inferior margin of the mass. (f)
Susceptibility signal intensity -time curve with regions of interest
over tumour (- - - - - - - -) and contralateral brain area (. . .. . .. . .)
shows high rCBV within the lesion. rCBV = 1.8. Final MRI
diagnosis after DTI and MR perfusion: high-grade glioma displac-
ing tracts with homogenous iso-intense signal in T1 with hyper-
intense signal in T2 and insigniﬁcant enhancement postcontrast
with increase perfusion which is indicated by signiﬁcantly high
rCBV and rCBF values. Histopathological report: High grade
(grade III & IV WHO grading).
3
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Fig. 6 Male patient (58 y old) complain from convulsions & dysarthria. (a–c) T2 & T1 (Pre- & Post-contrast) weighted MR imaging
shows the following: heterogenous mass lesion with area of cystic component and necrosis involving the cortex and subcortical white
matter at left temperoparieto-occipital region, appears as hypointense in T1, heterogenous hyperintense in T2, with perifocal oedema &
heterogenous enhancement in T1 postcontrast. (d) Color coded FA image & quantitative FA image show: Min/Max FA & mean FA for
tumour area (1), perifocal area (2) & necrotic area (3) as marked above in corresponding image. (e) 3D tractography showing displacement
of the left optic radiation inferomedially & ipsilateral meyer”s loop is crossing along the inferior margin of the mass. (f) Susceptibility
signal intensity -time curve with regions of interest over tumour (- - - - - - - -) and contralateral brain area (. . .. . .. . .) shows high rCBV within
the lesion. rCBV = 4.2. Final MRI diagnosis after DTI and MR perfusion: high-grade glioma displacing tracts with high FA values &
heterogeneous signal and enhancement postcontrast with area of necrosis & increase vascularity which is further conﬁrmed by signiﬁcantly
high rCBV value. Histopathological report: High grade (grade III & IV WHO grading).
250 E.A.SH. Geneidi et al.studies by Inoue et al., 2005; Beppu et al., 2005 and Kinoshita
et al., 2008 (21–23).
The mechanisms underlying the higher FA values in HGG
are complex but can be attributed to the following factors as
hypothesized by various authors: Higher tumour cellularity
in HGG may positively correlate with higher FA values
(24,25). Increase in the degree of directionality of water diffu-
sion due to decrease in extracellular volume (increased cellular-
ity) may also induce increased FA values (25). The pseudoFig. 5 Female (12 y old) complaining headache, & weakness in her
imaging shows heterogenous mass lesion with both cystic and solid com
heterogenous contrast enhancement in T1 postcontrast. (d) Color coded
FA & mean FA values for tumour (2) & perifocal area (3) & nec
tractography showing compression of corticospinal tracts & displa
Susceptibility signal intensity -time curve with regions of interest over t
rCBV within the lesion. rCBV = 0.9. Final MRI diagnosis after DTI
inﬁltrating with low FA values, which is further conﬁrmed by low rC
3palisading structure in glioblastomas may contribute to the
higher FA values similar to the high FA values in meningioma
(26).
Our preliminary study not only demonstrate the role of
Min, Max & Mean FA in grading of gliomas, but also pro-
vided the FA color map, which could easily visualize the
tumour content with high FA value. This might be useful in
guiding stereotactic biopsy of gliomas, which could easily visu-
alize the tumour content with high FA value. FA Color mapsextremities. (a–c) T2 & T1 (Pre- & Post-contrast) weighted MR
ponents noted within pons, hypointense T1, hyperintense T2, and
FA image & quantitative FA image show the following: Min/Max
rotic area (1) as marked above in corresponding image. (e) 3D
ced anteriorly & laterally by the lesion with sparsed ﬁbres (f)
umour (- - - - - - - -) and contralateral brain area (. . .. . .. . .) shows low
and MR perfusion: low-grade glioma displacing tracts rather than
BV. Pathology report: Low grade (grade I & II WHO grading).
Fig. 7 Male (35 y old) patient present with severe interactable headache, vomitting. (a) & (b) T2 & T1 (Post-contrast) weighted MR
imaging shows large heterogenous mass lesion epicentred on right fronto-parietal region 5  4.5 cm, extending to the contralateral side
with invasion of corpus callosum with positive mass effect. Exhibiting hyperintense T2, and heterogenous enhancement in T1
postcontrast. (c) Color coded FA image & quantitative FA image show the following: Min/Max FA & mean FA for tumour (2) &
perifocal area (3) & necrotic area (1) as marked above in corresponding image. (d) 3D tractography showing destruction and inﬁltration of
right corticospinal tract compared to left. (e) Susceptibility signal intensity-time curve with regions of interest over tumour (- - - - - - - - -) and
contralateral brain (. . .. . .. . .) shows high rCBV ratio within the lesion. rCBV = 2.9. Final MRI diagnosis after DTI and MR perfusion:
high-grade glioma due to multilocality, crossing midline with necrosis & displacing tracts with high FA values, which is further conﬁrmed
by high rCBV. Pathology report: high-grade (grade III & IV WHO grading).
Potential role of quantitative MRI assessment 251in DTI also help in accurate depiction of early recurrent or
residual tumour foci for accurate treatment plans.
The sensitivity, speciﬁcity & accuracy for FA parameters
according to their cut-off values in different areas of the
tumour were recorded in our study, yet for any comparison,
we need same standards to be scientiﬁcally & statistically
dependable. There were no clear dependable cut-off values
for Min, Max & Mean FA in previous studies to compare with
our results, because of differences in samples sizes, ROIs,
parameters & the ways parameters were calculated from our
study.
The perfusion data of the brain tumours are expressed in
terms of rCBV (relative cerebral blood volume), rCBF (relative
cerebral blood ﬂow) and MTT (mean transit time), however
rCBV is the most important in grading of gliomas followed
by rCBF which plays a less important role in tumour differen-
tiation and grading (27).
Wong et al. study reported a signiﬁcant difference in rCBV
between high-grade and low-grade gliomas, with low-grade
gliomas often having homogenously low rCBV and high-
grade gliomas exhibiting varying degrees of high rCBV. Againno single constant rCBV value could be given for each group
(28).
Lev et al. study reported that rCBV for low-grade gliomas
is less than 1.5 ± 1.1 and the mean rCBV for high-grade glio-
mas is about 2.9 ± 1.5 (29). Covarrubias et al.’s study further
agreed with Lev et al.’s study monitoring rCBV values greater
than 1.5 to be indicative for high-grade gliomas and homoge-
nously low rCBV less than 1.5 to be seen in most histologically
proven low-grade gliomas (30).
Law et al. study reported in a study performed on 160
patients with cerebral gliomas, that rCBV cut-off ratio of
1.75 was a sensitive, but not speciﬁc, marker for high-grade
histopathology, as all high-grade tumours had rCBV values
greater than 1.75. No tumour with rCBV less than 1.75 was
high-grade glioma (100% predictive value for excluding high
grade) (18).
However, increased tumour vascularity can also be found
in LGG, which will result in an elevated rCBV ratio. The pilo-
cytic astrocytoma (WHO grade I), although biologically
benign, has been described to exhibit histological evidence of
angiogenesis and elevated rCBV ratio (31).
252 E.A.SH. Geneidi et al.The low-grade oligodendrogliomas have also been reported
to show elevated rCBV ratio due to their inherent dense
network of branching capillaries resembling a ‘‘chicken
wire ‘‘pattern. Xu et al. found no signiﬁcant difference in
rCBV ratio between low- and high-grade oligo- dendrogliomas
(32).
Lev et al. reported that 50% of low-grade oligoden-
drogliomas presented elevated rCBV ratio (29).
Our study agrees with the studies by Lev et al. and Covar-
rubias et al. in rCBV ratio role for glioma grading but differs in
cut-off values. For low-grade gliomas, they were ranging from
0.45 to 1.2 with mean value of rCBV 0.79 and rCBV ratio for
high-grade gliomas ranging from 1.6 to 4.2 with mean value
2.62 & there was no HGG rCBV ratio less than 1.6 which
agrees with Covarrubias et al. study.
The difference in values of cut-off between our study and
the studies by Lev et al. and Covarrubias et al. was due to lar-
ger sample size & involving cases of LGG with high rCBV
ratio that were not faced in our study.
In our study, rCBV were with high sensitivity & speciﬁcity
reaching 100% for each in differentiation between HGG &
LGG with cut-off value >1.2. rCBV cut-off value of (1.2)
was considered as a sensitive & speciﬁc marker to predict
high-grade gliomas as none of the examined low-grade gliomas
showed rCBV higher than cut-off.
Though our study shows a good role for discrimination, the
drawback in our study was a small sample size. We need fur-
ther research & evaluation with a larger sample size & to do
Meta analysis to be clinically applicable in the future. Regard-
ing DTI (FA values), during determination of ROI to measure
FA values, we should take in our consideration the values in
contralateral area to calculate a corrected value as a ratio
rather than a value. Also Computer-aided voxel-based semi-
automated segmentation techniques may reduce the subjective
bias inherent in manual ROI placement.
From the data obtained from our study, we can conclude
that perfusion imaging is valuable in grading of cerebral glio-
mas by using the rCBV to give important information about
the underlying neovascularity of the tumour regardless of the
enhancement pattern of the lesion which agrees with Law
et al., 2004 study (17).
The use of MR DTI had an important role in the grading of
brain gliomas as it was accurate in grading 24 cases of gliomas
(sensitivity of 100% and accuracy 100%).
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